Armata Pharmaceuticals, Inc. — Director's Dealing 2021

Jun 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Armata Pharmaceuticals, Inc. (ARMP)
CIK: 0000921114
Period of Report: 2021-06-07

Reporting Person: PATTI JOSEPH M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-07	Stock Option (Right to Buy)	$4.29	A	28000	Acquired	2031-06-07	Common Stock (28000)	Direct

Footnotes

F1: The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant.